Pfizer COVID-19 pill could cut severe illness by 89%, company saysNovember 05, 2021 at 08:17 AM EDT
 
Pfizer Inc. announced Friday that its pill to treat novel COVID-19 was found to reduce the risk of hospitalization or death by 89% among high-risk adult patients in a clinical trial.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
| ||||||
| Home | Hot | SubjectMarks | PeopleMarks | Keepers | Settings |
| Terms Of Use | Contact Us | Copyright/IP Policy | Privacy Policy | About Us | FAQ | Advertise on SI |
| Copyright © 1995-2016 Knight Sac Media. All rights reserved. | Stock quotes are delayed at least 15 minutes - See Terms of Use. |